Clinical Trials for Pyxis Oncology

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pyxis Oncology

Clinical Trials (5)

Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

PHASE1/PHASE2Recruiting

200 participants

Started: Apr 15, 2025 · Completed: Dec 6, 2027

1 condition2 sponsors7 locations

Study of PYX-106 in Solid Tumors

PHASE1Active, not recruiting

47 participants

Started: May 23, 2023 · Completed: May 31, 2026

1 condition1 sponsor20 locations

Study of PYX-201 in Solid Tumors

PHASE1Recruiting

330 participants

Started: Mar 14, 2023 · Completed: May 31, 2027

2 conditions1 sponsor20 locations

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

PHASE1Active, not recruiting

32 participants

Started: Mar 1, 2018 · Completed: Nov 1, 2025

6 conditions7 sponsors11 locations

APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma

PHASE1/PHASE2Active, not recruiting

32 participants

Started: Jun 2, 2017 · Completed: Apr 30, 2025

1 condition3 sponsors1 location